S Taucher

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi request reprint Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer
    Catharina Wenzel
    Department of Internal Medicine I Division of Oncology, University Hospital of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Cancer Chemother Pharmacol 50:155-9. 2002
  2. pmc Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group
    Raimund Jakesz
    Department of Surgery, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Ann Surg 237:556-64. 2003
  3. ncbi request reprint Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy
    Margaretha Rudas
    Department of Pathology, University of Vienna, Vienna, Austria
    Breast Cancer Res Treat 81:149-57. 2003
  4. ncbi request reprint Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer
    Richard Potter
    Department of Surgery, Medical University of Vienna, Vienna, Austria
    Int J Radiat Oncol Biol Phys 68:334-40. 2007
  5. ncbi request reprint Impact of pretreatment thrombocytosis on survival in primary breast cancer
    Susanne Taucher
    Department of Surgery, University of Vienna Medical School, Waehringer Guertel 18 20, Vienna A 1090, Austria
    Thromb Haemost 89:1098-106. 2003
  6. ncbi request reprint Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer
    Susanne Taucher
    Department of Surgery, Vienna University Medical School, Vienna, Austria
    Wien Klin Wochenschr 116:26-31. 2004
  7. ncbi request reprint Survival after surgical treatment of breast cancer
    Susanne Taucher
    Department of Surgery, Vienna University Medical School, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Langenbecks Arch Surg 389:75-82. 2004
  8. ncbi request reprint Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer
    Susanne Taucher
    Department of Surgery, Vienna University Medical School, Vienna, Austria
    Breast Cancer Res Treat 82:207-13. 2003
  9. ncbi request reprint Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene
    Susanne Taucher
    Department of Surgery, Medical School, Vienna University, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Langenbecks Arch Surg 388:3-8. 2003
  10. ncbi request reprint Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy
    S Taucher
    Department of Surgery, Vienna University Medical School, Waehringer Guertel 18 20, Vienna A 1090, Austria
    Endocr Relat Cancer 10:91-8. 2003

Collaborators

Detail Information

Publications23

  1. ncbi request reprint Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer
    Catharina Wenzel
    Department of Internal Medicine I Division of Oncology, University Hospital of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Cancer Chemother Pharmacol 50:155-9. 2002
    ....
  2. pmc Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group
    Raimund Jakesz
    Department of Surgery, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Ann Surg 237:556-64. 2003
    ..To confirm evidence that breast-conserving treatment (BCT) does not impair the prognosis in breast cancer patients as compared to mastectomy and to argue that it be regarded as the treatment of choice in stage I and II disease...
  3. ncbi request reprint Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy
    Margaretha Rudas
    Department of Pathology, University of Vienna, Vienna, Austria
    Breast Cancer Res Treat 81:149-57. 2003
    ..Response to chemotherapy is not associated with pre- or postchemotherapy expression levels of these drug resistance proteins but time to progression may be influenced by prechemotherapy MRP1 expression...
  4. ncbi request reprint Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer
    Richard Potter
    Department of Surgery, Medical University of Vienna, Vienna, Austria
    Int J Radiat Oncol Biol Phys 68:334-40. 2007
    ..In women with favorable early breast cancer treated by lumpectomy plus tamoxifen or anastrazole, it remains unclear whether whole breast radiotherapy is beneficial...
  5. ncbi request reprint Impact of pretreatment thrombocytosis on survival in primary breast cancer
    Susanne Taucher
    Department of Surgery, University of Vienna Medical School, Waehringer Guertel 18 20, Vienna A 1090, Austria
    Thromb Haemost 89:1098-106. 2003
    ..1355). In our retrospective study, elevated platelet counts at time of diagnosis were associated with poor prognosis in breast cancer. We hypothesize that platelets may contribute to the pathophysiology of hematogenous metastasis...
  6. ncbi request reprint Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer
    Susanne Taucher
    Department of Surgery, Vienna University Medical School, Vienna, Austria
    Wien Klin Wochenschr 116:26-31. 2004
    ..Since core needle biopsy is increasingly used for the diagnosis of breast cancer, the purpose of this study was to assess the reliability of HER2/neu evaluation using this technique in patients with primary breast cancer...
  7. ncbi request reprint Survival after surgical treatment of breast cancer
    Susanne Taucher
    Department of Surgery, Vienna University Medical School, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Langenbecks Arch Surg 389:75-82. 2004
    ..e. complete resection with tumour-free margins. Type and extent of breast surgery is dependent on tumour stage; beyond that and even more importantly, prognosis of an individual patient depends upon its stage at diagnosis...
  8. ncbi request reprint Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer
    Susanne Taucher
    Department of Surgery, Vienna University Medical School, Vienna, Austria
    Breast Cancer Res Treat 82:207-13. 2003
    ....
  9. ncbi request reprint Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene
    Susanne Taucher
    Department of Surgery, Medical School, Vienna University, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Langenbecks Arch Surg 388:3-8. 2003
    ..Despite the reduction in the risk of developing breast cancer, prophylactic mastectomy often leads to significant physical and psychological sequelae...
  10. ncbi request reprint Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy
    S Taucher
    Department of Surgery, Vienna University Medical School, Waehringer Guertel 18 20, Vienna A 1090, Austria
    Endocr Relat Cancer 10:91-8. 2003
    ..Preoperative cytotoxic chemotherapy induced a significant extent of variation in the steroid receptor expression of breast cancer cells...
  11. doi request reprint Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy
    Peter Dubsky
    Department of Surgery, Medical University Vienna, Vienna, Austria
    Clin Cancer Res 14:2082-7. 2008
    ....
  12. ncbi request reprint High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS
    S Roka
    Department of General Surgery, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Eur J Surg Oncol 30:243-7. 2004
    ..Recommendations for adjuvant treatment of DCIS after breast conservation are controversial. We tried to identify further risk factors in a retrospective study of our own practice...
  13. ncbi request reprint Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer
    E Janschek
    Department of Surgery, University of Vienna, Austria
    Breast Cancer Res Treat 67:1-8. 2001
    ..We could also demonstrate that contralateral breast cancer spread does occur. Standard pathological assessment allowed a firm diagnosis only in the presence of different histological types...
  14. pmc Haemophilus parainfluenzae liver abscess after successful liver transplantation
    J Friedl
    Department of Surgery, University of Vienna, Austria
    J Clin Microbiol 36:818-9. 1998
    ..Drug therapy, immunosuppression, rejection therapy, and Roux-en-Y choledochojejunostomy may have contributed to the septic course. Interdisciplinary cooperation was instrumental in diagnosis and successful management in this case...
  15. ncbi request reprint Ultrasound-guided core needle biopsy of the breast: does frozen section give an accurate diagnosis?
    Elisabeth Mueller-Holzner
    Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria
    Breast Cancer Res Treat 106:399-406. 2007
    ..Immediate investigation of CNB in frozen sections is an accurate diagnostic method and an important step in reducing psychological strain on patients with breast tumors and may be offered by specialised Breast Assessment Units...
  16. ncbi request reprint Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients
    Florian Fitzal
    Department of Surgery, General Hospital, University Vienna, Waehringer Guertd 18 20, 1090 Vienna, Austria
    Breast Cancer Res Treat 97:9-15. 2006
    ..The impact of this observation on local recurrence and overall survival rate is, however, not fully investigated...
  17. pmc Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer
    Sebastian F Schoppmann
    Department of Surgery, Medical University of Vienna, Austria
    Ann Surg 240:306-12. 2004
    ..The aim of this study was to investigate the prognostic relevance of lymphangiogenesis and lymphovascular invasion in a large cohort of breast cancer patients...
  18. ncbi request reprint Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor
    Catharina Wenzel
    Department of Internal Medicine I, Division of Oncology, University Hospital of Vienna, 1090 Vienna, Austria
    Anticancer Drugs 13:67-74. 2002
    ..Thus, this regimen can be considered for further clinical trials...
  19. ncbi request reprint Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer
    Peter C Dubsky
    Department of General Surgery, University of Vienna, Austria
    Clin Breast Cancer 3:65-72. 2002
    ..Future studies should focus on unveiling the young age surrogate in order to improve treatment and prognosis...
  20. ncbi request reprint Do we need HER-2/neu testing for all patients with primary breast carcinoma?
    Susanne Taucher
    Department of Surgery, Vienna University Medical School, Vienna, Austria
    Cancer 98:2547-53. 2003
    ..The objective of the current study was to investigate the probability, calculated using parameters that are assessed routinely in clinical practice, that patients with breast carcinoma had positive HER-2/neu status...
  21. ncbi request reprint Pattern of hormone receptor status of secondary contralateral breast cancers in patients receiving adjuvant tamoxifen
    Thomas Bachleitner-Hofmann
    Department of Surgery, University of Vienna, A 1090 Vienna, Austria
    Clin Cancer Res 8:3427-32. 2002
    ....
  22. ncbi request reprint Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy
    Gudrun Pohl
    Department of Internal Medicine 1, Division of Oncology, University Hospital, Vienna, Austria
    Breast Cancer Res Treat 78:97-103. 2003
    ....
  23. ncbi request reprint Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6
    Marianne Schmid
    Medical Department, Graz University, and Second Department of Surgery, Graz Hospital, Graz, Austria
    J Clin Oncol 21:984-90. 2003
    ..To determine whether the addition of aminoglutethimide to tamoxifen is able to improve the outcome in postmenopausal patients with hormone receptor-positive, early-stage breast cancer...